Despite the overall decline in KS incidence following the widespread availability of antiretroviral therapy (ART), its prevalence remains disproportionately high in individuals with low CD4 counts (<200 cells/mm3) and persistent HIV viremia [3]. Here, CD4 is linked to Kaposi's sarcoma.